Cardlytics (CDLX) Tops Q3 EPS by 42c
Cardlytics (NASDAQ: CDLX) reported Q3 EPS of ($0.15), $0.42 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $67.06 million versus the consensus estimate of $57.71 million.
For earnings history and earnings-related data on Cardlytics (CDLX) click here.
